Nexien BioPharma NXEN Stock
Nexien BioPharma Price Chart
Nexien BioPharma NXEN Financial and Trading Overview
Nexien BioPharma stock price | 0.0100 USD |
Previous Close | 0.04 USD |
Open | 0.03 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.03 - 0.04 USD |
52 Week Range | 0.02 - 0.1 USD |
Volume | 3.02K USD |
Avg. Volume | 5.82K USD |
Market Cap | 2.03M USD |
Beta (5Y Monthly) | 1.415492 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NXEN Valuation Measures
Enterprise Value | 2.82M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Nexien BioPharma Stock Price History
Beta (5Y Monthly) | 1.415492 |
52-Week Change | -53.62% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.1 USD |
52 Week Low | 0.02 USD |
50-Day Moving Average | 0.04 USD |
200-Day Moving Average | 0.04 USD |
NXEN Share Statistics
Avg. Volume (3 month) | 5.82K USD |
Avg. Daily Volume (10-Days) | 5.35K USD |
Shares Outstanding | 63.52M |
Float | 18.52M |
Short Ratio | N/A |
% Held by Insiders | 54.17% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -177.94% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | -365320 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 54.21K USD |
Total Cash Per Share (mrq) | 0.001 USD |
Total Debt (mrq) | 266.09K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.202 |
Book Value Per Share (mrq) | -0.004 |
Cash Flow Statement
Operating Cash Flow (ttm) | -86010 USD |
Levered Free Cash Flow (ttm) | -179270 USD |
Profile of Nexien BioPharma
Country | United States |
State | CO |
City | Glendale |
Address | 4340 East Kentucky Avenue |
ZIP | 80246 |
Phone | 303 495 7583 |
Website | https://www.nexienbiopharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. The company is based in Glendale, Colorado.
Q&A For Nexien BioPharma Stock
What is a current NXEN stock price?
Nexien BioPharma NXEN stock price today per share is 0.0100 USD.
How to purchase Nexien BioPharma stock?
You can buy NXEN shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nexien BioPharma?
The stock symbol or ticker of Nexien BioPharma is NXEN.
Which industry does the Nexien BioPharma company belong to?
The Nexien BioPharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Nexien BioPharma have in circulation?
The max supply of Nexien BioPharma shares is 70.77M.
What is Nexien BioPharma Price to Earnings Ratio (PE Ratio)?
Nexien BioPharma PE Ratio is now.
What was Nexien BioPharma earnings per share over the trailing 12 months (TTM)?
Nexien BioPharma EPS is 0 USD over the trailing 12 months.
Which sector does the Nexien BioPharma company belong to?
The Nexien BioPharma sector is Healthcare.